Gilead Sciences (GILD) Misses Q1 EPS by 16c, Revenues Beat; Guides Revenue Below
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $146.85 +1.82%
EPS Growth %: -14.2%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
AEHR, VFS, CMTL, More
EPS Growth %: -14.2%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $1.37, $0.16 worse than the analyst estimate of $1.53. Revenue for the quarter came in at $6.4 billion versus the consensus estimate of $6.31 billion.
GUIDANCE:
Gilead Sciences sees FY2023 EPS of $6.60-$7.00, versus the consensus of $6.84. Gilead Sciences sees FY2023 revenue of $26-26.5 billion, versus the consensus of $26.73 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Levi (LEVI) Tops Q3 EPS by 12c; raises guidance
- Levi Strauss beats profit forecasts, shares edge higher
- Lamb Weston (LW) Tops Q1 EPS by 15c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
